The aglycone binding site of UDP-glucuronosyltransferase 2B7

被引：0
|
作者：
Coffman, BL [1 ]
Kearney, WR [1 ]
Goldsmith, S [1 ]
Knosp, BM [1 ]
Tephly, TR [1 ]
机构：
[1] Univ Iowa, Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA
来源：
FASEB JOURNAL | 2003年 / 17卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A608 / A608
页数：1
相关论文
共 50 条
  • [41] Characterisation of interactions between UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates using multisite kinetic modelling
    Uchaipichat, Verawan
    Mackenzie, Peter
    Houston, Brian
    Galetin, Aleksandra
    Miners, John
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 218 - 218
  • [42] Regulation of the human UDP-glucuronosyltransferase 2B7.
    Czernik, PJ
    Guo, LX
    Radominska-Pandya, A
    FASEB JOURNAL, 1999, 13 (07): : A1409 - A1409
  • [43] Homodimerization of UDP-glucuronosyltransferase 2B7 (UGT2B7) and identification of a putative dimerization domain by protein homology modeling
    Lewis, Benjamin C.
    Mackenzie, Peter I.
    Miners, John O.
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (12) : 2016 - 2023
  • [44] The function of uterine UDP-glucuronosyltransferase 1A8 (UGT1A8) and UDP-glucuronosyltransferase 2B7 (UGT2B7) is involved in endometrial cancer based on estrogen metabolism regulation
    Zhao, Feng
    Wang, Xi
    Wang, Yan
    Zhang, Jingbo
    Lai, Ran
    Zhang, Bei
    Zhou, Xueyan
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 19 (03): : 403 - 412
  • [45] 3′-azido-3′-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7)
    Barbier, O
    Turgeon, D
    Girard, C
    Green, MD
    Tephly, TR
    Hum, DW
    Bélanger, A
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (05) : 497 - 502
  • [46] Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: Implications for in vitro-in vivo extrapolation
    Rowland, Andrew
    Gaganis, Paraskevi
    Elliot, David J.
    Mackenzie, Peter I.
    Knights, Kathleen M.
    Miners, John O.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (01): : 137 - 147
  • [47] Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7
    Miley, Michael J.
    Zielinska, Agnieszka K.
    Keenan, Jeffrey E.
    Bratton, Stacie M.
    Radominska-Pandya, Anna
    Redinbo, Matthew R.
    JOURNAL OF MOLECULAR BIOLOGY, 2007, 369 (02) : 498 - 511
  • [48] Commonly Used Excipients Modulate UDP-Glucuronosyltransferase 2B7 Activity to Improve Nalbuphine Oral Bioavailability in Humans
    Hong-Jaan Wang
    Cheng-Huei Hsiong
    Shung-Tai Ho
    Min-Jen Lin
    Tung-Yuan Shih
    Pei-Wei Huang
    Oliver Yoa-Pu Hu
    Pharmaceutical Research, 2014, 31 : 1676 - 1688
  • [49] Extensive Protein-Protein Interactions Involving UDP-glucuronosyltransferase (UGT) 2B7 in Human Liver Microsomes
    Fujiwara, Ryoichi
    Itoh, Tomoo
    DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (03) : 259 - 265
  • [50] 3D-QSAR studies on UDP-glucuronosyltransferase 2B7 substrates using the pharmacophore and VolSurf approaches
    Ako, Roland
    Dong, Dong
    Wu, Baojian
    XENOBIOTICA, 2012, 42 (09) : 891 - 900
12345